KIRAX
Kirax Corporation, a biopharmaceutical company, engages in acquiring, developing, and commercializing specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. Its product pipeline includes AFP-464, an anti-cancer agent in patients with breast cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that appears to induce apoptosis by down-regulating several pivotal oncogenic and tumor survival... pathways; and GFB-204, a calixarene derivative that is an inhibitor of VEGFR and PDGFR tyrosine phosphorylation. The company licenses or acquires rights to compounds in various stages of clinical development, as well as in-market products. Kirax Corporation was formerly known as Tigris Pharmaceuticals, Inc. The company was founded in 2005 and is based in Bonita Springs, Florida.
KIRAX
Industry:
Biopharma Biotechnology Medical
Founded:
2005-01-01
Address:
Bonita Springs, Florida, United States
Country:
United States
Website Url:
http://www.kiraxcorp.com
Total Employee:
1+
Status:
Active
Contact:
2394445405
Email Addresses:
[email protected]
Total Funding:
540.76 K USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
